Related Experiment Videos
Expression of matrix metalloproteinases in a series of 12 meningiomas
E Kirches1, J Grunewald, P von Bossanyi
1Institute for Neuropathology of the University of Magdeburg, Germany. elmar.kirches@medizin.uni-magdeburg.de
Abstract:
The expression of metalloproteinases was evaluated in a series of 12 meningiomas of various histological subtypes including 3 meningotheliomatous, 3 fibroblastic, 4 transitional and one psammomatous meningioma (WHO grade I) as well as one anaplastic meningioma (WHO grade III). No gelatinolytic activity could be detected in all tumor samples pointing towards no or very low activity of both MMP-2 and MMP-9. At least MMP-2 mRNA could be found in 10 out of 12 tumor samples by the reverse transcription PCR method (RT-PCR) followed by electrophoresis on silver-stained polyacrylamide gels, which allows the detection even of small traces of a specific mRNA. The PCR products were identified as MMP-2 sequences without introns (mRNA-derived) by direct sequencing, thereby demonstrating a low transcriptional activity of the gene. The translation of these mRNAs, however, did not result in amounts of protein detectable by immunohistochemistry or Western blotting. Therefore, neither MMP-2 nor MMP-9 should play a major role for tumor growth within dura mater or bone structures or for brain infiltration in our tumor series. Therefore, other mechanisms must be responsible for extracellular matrix degradation at least in a fraction of meningiomas.
Insights
Matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-9, show minimal protein expression in meningiomas. Despite detectable messenger RNA (mRNA), low protein levels suggest other mechanisms drive extracellular matrix degradation in these tumors.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Biochemistry
Background:
- Meningiomas are primary tumors of the meninges.
- Extracellular matrix (ECM) degradation is crucial for tumor invasion and growth.
- Matrix metalloproteinases (MMPs) are key enzymes involved in ECM remodeling.
Purpose of the Study:
- To investigate the expression and activity of MMP-2 and MMP-9 in various meningioma subtypes.
- To determine the role of MMP-2 and MMP-9 in meningioma progression and invasion.
Main Methods:
- Analysis of 12 meningioma samples (WHO grades I and III).
- Assay for gelatinolytic activity (MMP-2, MMP-9).
- Reverse transcription PCR (RT-PCR) for MMP-2 mRNA detection.
- Sequencing of PCR products.
- Immunohistochemistry and Western blotting for protein detection.
Main Results:
- No detectable gelatinolytic activity for MMP-2 or MMP-9 in any meningioma sample.
- MMP-2 mRNA detected in 10 out of 12 samples via RT-PCR.
- Sequencing confirmed mRNA-derived MMP-2 sequences, indicating low transcriptional activity.
- No detectable MMP-2 or MMP-9 protein levels via immunohistochemistry or Western blotting.
Conclusions:
- MMP-2 and MMP-9 protein expression and activity are negligible in this series of meningiomas.
- These MMPs likely do not play a significant role in meningioma growth or brain infiltration.
- Alternative mechanisms are responsible for ECM degradation in meningiomas.